These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2150910

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Ljungdahl A, Höjeberg B, Link J, He B, Qiao J, Melms A, Olsson T.
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [Abstract] [Full Text] [Related]

  • 24. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H.
    Ann N Y Acad Sci; 1996 Feb 13; 778():273-87. PubMed ID: 8610980
    [Abstract] [Full Text] [Related]

  • 25. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
    Im SH, Barchan D, Souroujon MC, Fuchs S.
    J Immunol; 2000 Oct 01; 165(7):3599-605. PubMed ID: 11034361
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis.
    Krolick KA, Zoda TE, Thompson PA.
    Adv Neuroimmunol; 1994 Oct 01; 4(4):475-93. PubMed ID: 7719619
    [Abstract] [Full Text] [Related]

  • 28. Oral tolerance in myasthenia gravis.
    Drachman DB, Okumura S, Adams RN, McIntosh KR.
    Ann N Y Acad Sci; 1996 Feb 13; 778():258-72. PubMed ID: 8610979
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
    Wang ZY, He B, Qiao J, Link H.
    J Neuroimmunol; 1995 Dec 13; 63(1):79-86. PubMed ID: 8557828
    [Abstract] [Full Text] [Related]

  • 33. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB, Li H, He B, Bakheit M, Levi M, Wahren B, Berglöf A, Sandstedt K, Link H, Shi FD.
    Biomed Pharmacother; 1999 Jun 13; 53(5-6):227-33. PubMed ID: 10424244
    [Abstract] [Full Text] [Related]

  • 34. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases.
    Nossal GJ.
    Ann N Y Acad Sci; 1987 Jun 13; 505():610-8. PubMed ID: 3500669
    [No Abstract] [Full Text] [Related]

  • 35. Neonatal tolerance to an immunodominant T cell reactivity does not confer resistance to EAMG induction in Lewis rats.
    Zoda TE, Brandon K, Krolick KA.
    J Neuroimmunol; 1995 Mar 13; 57(1-2):35-44. PubMed ID: 7535790
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM, Einarson BL, Lennon VA, Seybold ME.
    J Exp Med; 1976 Sep 01; 144(3):726-38. PubMed ID: 182896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.